Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis

International Journal of Cancer

Volumn 96, Issue 4, 2001, Pages 213-220

  Sheard, Michael A ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Apoptosis; CD95 Fas APO 1; Ionizing radiation; P53 Trp53

Indexed keywords

APC PROTEIN; CELL SURFACE PROTEIN; DOXORUBICIN; FAS ANTIGEN; LIGAND; PROTEIN P53; TAXANE DERIVATIVE;

APOPTOSIS; CELL DEATH; DNA DAMAGE; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IONIZING RADIATION; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; HUMANS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTES; MODELS, BIOLOGICAL; NEOPLASMS; RADIATION, IONIZING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0035921189     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1020     Document Type: Review

References (84)

1. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
2. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease
3. Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
4. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines
5. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
6. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
7. Tumor immunity in perforin-deficient mice: A role for CD95 (Fas/APO-1)
8. Molecular mechanisms of immune-mediated lysis of murine renal cancer: Differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells
9. Perforin is a major contributor to NK cell control of tumor metastasis
10. Decreased tumor surveillance in perforin-deficient mice
11. Radiation-induced apoptosis: Relevance to radiotherapy
12. Radiation-induced apoptotic cell death in human gastric epithelial tumor cells: Correlation between mitotic death and apoptosis
13. Development of apoptosis and polyploidy in human lymphoblast cells as a function of position in the cell cycle at the time of irradiation
14. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis
15. p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines
16. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis
17. Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo
18. The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation
19. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
20. Radiation and stress-induced apoptosis: A role for Fas/Fas ligand interactions
21. Activation of the CD95 (APO-1/Fas) pathway in drug- and γ-irradiation-induced apoptosis of brain tumor cells
22. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs
23. Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling: Implications for cancer therapy
24. CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types
25. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression
26. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
27. Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions
28. Fractionated γ-irradiation renders tumour cells more responsive to apoptotic signals through CD95
29. p53-mediated upregulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells
30. CD95(APO-1/Fas)-mediated apoptosis: Live and let die
31. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II
32. Resistance to Fasmediated apoptosis in human hepatoma cells
33. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis
34. Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines
35. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
36. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis
37. Fas-dependent tissue turnover is implicated in tumor cell clearance
38. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
39. p53 promotes selection for Fas-mediated apoptotic resistance
40. Fas and Fas ligand interactions suppress melanoma lung metastasis
41. Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand
42. Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells
43. Ionizing radiation alters Fas antigen ligand at the cell surface and on exfoliated plasma membrane-derived vesicles: Implications for apoptosis and intercellular signaling
44. The Fas counterattack: Cancer as a site of immune privilege
45. Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape
46. Tumor counterattack - Concept and reality
47. Cutting edge: The tumor counterattack hypothesis revisited: Colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway
48. Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation
49. Ionizing radiation inhibits chemotherapy-induced apoptosis in cultured glioma cells: Implications for combined modality therapy
50. Enhanced apoptosis of squamous cell carcinoma cells by interleukin-2-activated cytotoxic lymphocytes combined with radiation and anticancer drugs
51. Tumor necrosis factor-α sensitizes prostate cancer cells to γ-irradiation-induced apoptosis
52. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
53. Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit the colonization of premalignant human breast cells overexpressing cyclin D1
54. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity
55. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system
56. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin
57. Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression
58. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
59. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly
60. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death
61. Bcl-X and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells
62. Sensitivity of S49.1 cells to anti-CD95 (Fas/APO-1)-induced apoptosis: Effects of CD95, Bcl-2 or Bcl-X transduction
63. INF-gamma-dependent delay of in vitro tumor progression by Fas overexpression on murine renal cancer cells
64. Wild-type human p53 and a temperature sensitive mutant induce Fas/APO-1 expression
65. Tissue and cell-specific expression of the p53-target genes bax, fas, mdm2 and waf1/p21 before and following ionising irradiation in mice
66. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis
67. wild-type cancer cells treated with ionizing radiation
68. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
69. Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines
70. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor
71. + T cells secreting Th1 or Th2 cytokines
72. Lymphokine-activated killer cells, natural killer cell and cytokines
73. + tumor-infiltrating lymphocytes
74. Cytokine production and expression of adhesion molecules and integrins in tumor infiltrating lymphomononuclear cells of non-small cell carcinomas of the lung
75. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer
76. Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma
77. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes
78. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines
79. Potentiation of Fas-mediated apoptosis of murine granuloma cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide
80. Building better vaccines: How apoptotic cell death can induce inflammation and activate innate and adaptive immunity
81. Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines
82. + T cells for efficient tumor cell lysis
83. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells
84. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: Critical role in migration from the tumor site to draining lymph nodes